Cybersecurity in pharma and medical devices: obligations under the Polish act implementing NIS2 (KSC)
In the Polish act implementing NIS2 (KSC), the subsector for the production and distribution of active substances, medicinal products and medical devices belongs to the healthcare sector in Annex 1. It covers among others manufacturers and importers of medicinal products, marketing authorisation holders, pharmaceutical wholesalers, community pharmacies, distributors of active substances and manufacturers of medical devices considered critical during a public health emergency.
The continuity of medicine supply depends on the systems that support production, quality control, warehouses, pharmacy orders and patient data. The KSC Act, which implements the NIS2 Directive, covers this chain from the manufacturer to the pharmacy, and for pharmaceutical companies in Poland the category depends mainly on the size of the enterprise. CyberSonar24 combines the register of assets, suppliers, risks and incidents with the GDPR module in one system.
01
NIS2 for pharmaceutical companies in Poland: what sets the sector apart
- A chain from manufacturer to patient. The manufacturer, importer, wholesaler and pharmacy exchange data on orders, batches and deliveries. A failure at one link is quickly felt by the others.
- Quality systems and traceability. Batch records, quality control and warehouse systems must preserve data integrity, and losing them makes it harder to release or recall a product.
- Storage conditions. Temperature-controlled warehouses and systems that monitor storage conditions are critical assets.
- Pharmacy chains. Many outlets use the same central systems, and in groups the size of linked enterprises counts.
- Health data. Pharmacies and some wholesalers process patient data and prescriptions, so they apply the GDPR alongside the KSC Act.
02
Typical threats and incidents
- Ransomware encrypting data in warehouse and order systems.
- Phishing for login credentials to pharmacy and wholesaler systems.
- Theft of research and registration documentation.
- Failure of the storage condition monitoring system.
- An incident at a supplier of pharmacy software or logistics.
03
Obligations under the KSC Act
- Category. An undertaking in this subsector that exceeds the thresholds of a medium-sized enterprise is an essential entity, and a medium-sized one is an important entity (art. 5 para. 1 point 1 and para. 2 point 1). A small pharmacy is in principle not covered, unless the authority issues a decision under art. 7l. In groups, the data of linked enterprises count, with the exceptions in art. 5 para. 6 and 7.
- Public institutions in the subsector. Annex 1 also lists the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products and the offices serving the bodies of the Pharmaceutical Inspectorate.
- Information security management system under art. 8 para. 1, including supply chain security and business continuity plans, and documentation (art. 10).
- Significant incident. Early warning within 24 hours, notification within 72 hours, final report within one month (art. 11 para. 1 point 4, 4a and 4c), through the S46 system.
- Audit and deadlines. An essential entity carries out an audit at least once every 3 years (art. 15 para. 1). Entities covered from the date the amendment entered into force fulfil the obligations of chapter 3 by 3 April 2027 (art. 33 para. 1 of the amending Act).
04
How CyberSonar24 helps
Processes from production to dispensing (CyberSonar24 GRC).
A register of services and processes: manufacturing, quality control, warehouse, distribution, pharmacy support. The dependency graph shows which processes stop when a system or warehouse fails.
Criticality analysis.
Maximum tolerable downtime and maximum tolerable data loss for each process, with a warning when a critical process has no continuity plan.
Suppliers.
A supplier register with data from GUS by NIP number, contracts, service level agreements and certificates with expiry dates. The supplier risk assessment covers six areas.
Risk.
A risk register on a scale from 1 to 25 (1–4 Negligible, 5–9 Low, 10–14 Medium, 15–19 High, 20–25 Critical), with an owner and a review schedule.
Patient data (CyberSonar24 GDPR).
Records of processing activities, authorisations, data processing agreements, data protection impact assessments and data-subject requests with a response deadline. Personal data breaches are in the same module as incidents.
Training (CyberSonar24 E-learning).
Pharmacists and warehouse staff take courses in a computer or phone browser, with a test and a named certificate.
05
Typical rollout
- 01
Audit Zero. A free questionnaire shows the preliminary category and the areas to complete.
- 02
Presentation. We show the processes, the supplier register and the shared module for incidents and data breaches.
- 03
Deployment model. In the cloud or on the client’s servers (on-prem). Depending on the plan, one instance can serve several companies or sites.
- 04
Registers. The company enters processes, systems, warehouses and suppliers, including by import from Excel files.
- 05
Risks and continuity plans. Owners assess risks and prepare plans for warehouses and order systems.
- 06
Training and management review. Staff complete training, and the board receives the management review.
06 · Frequently asked questions
FAQ
Is every pharmacy subject to the Polish act implementing NIS2 (KSC)?
No. A community pharmacy is covered by the Act if it is at least a medium-sized enterprise: a medium-sized one is an important entity and a larger one an essential entity (art. 5 para. 1 point 1 and para. 2 point 1). In pharmacy chains, size is assessed together with linked enterprises, with the exceptions in art. 5 para. 6 and 7.
Is a pharmaceutical wholesaler an essential or an important entity?
That depends on size. A pharmaceutical wholesaler that exceeds the thresholds of a medium-sized enterprise is an essential entity, and a medium-sized one is an important entity. The same rule applies to manufacturers, importers and distributors of active substances.
Does a medical device manufacturer belong to pharma or to manufacturing?
A manufacturer of medical devices considered critical during a public health emergency belongs to the healthcare sector in Annex 1. Other manufacturers of medical devices and in vitro diagnostic medical devices belong to the manufacturing sector in Annex 2.
How can a pharmacy or wholesaler combine its obligations under the KSC Act and the GDPR?
In CyberSonar24, security incidents and personal data breaches are in one module, shared with CyberSonar24 GDPR. The GDPR module keeps records of processing activities, authorisations and data processing agreements.
